8
Oct
2024

Adalvo

Exhibitor at CPHI Milan 2024 stand 10B27, Finished Dosage Formulations
About Us

Adalvo is a leading B2B pharmaceutical company in Europe with over 110 global partners in 100+ countries. The company's goal is to improve patient care by providing high-quality products and services through a smart collaboration network. Adalvo's unique approach is tailored to each partner, helping them grow their business and achieve their objectives, whether that's increasing revenue or expanding into new markets. The company also prioritizes employee development and community growth while striving for excellence. Adalvo's commitment to excellence and making a difference ensures that it remains a key player in the competitive pharmaceutical industry.

  • MT
  • 2020
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Other
Primary activities
Out-licensing specialist
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 10B27, Finished Dosage Formulations